A retrospective chart analysis of 34 cases with the use of oral cerebroprotein hydrolysate in dementia in a tertiary general hospital
Background: Cerebroprotein hydrolysate (cerebrolysin) is a nootropic and neurotrophic drug used widely in the management of various forms of dementia, stroke and head injury. A number of case series and anecdotal case reports on its efficacy exist. This study is a retrospective chart review of 34 pa...
Main Authors: | Sagar Karia, Avinash Desousa, Nilesh Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Geriatric Mental Health |
Subjects: | |
Online Access: | http://www.jgmh.org/article.asp?issn=2348-9995;year=2021;volume=8;issue=1;spage=30;epage=33;aulast=Karia |
Similar Items
-
The use of cerebroprotein hydrolysate in dementia: A case series of 25 cases seen in a tertiary general hospital
by: Mosam Phirke, et al.
Published: (2014-01-01) -
Cerebroprotein Hydrolysate-I Inhibits Hippocampal Neuronal Apoptosis by Activating PI3K/Akt Signaling Pathway in Vascular Dementia Mice
by: Wu X, et al.
Published: (2021-07-01) -
Higher mental functioning in dementia: A status assessment
by: Rajesh Kumar, et al.
Published: (2015-01-01) -
Effect of monosialotetrahexosylganglioside sodium combined with cerebroprotein hydrolysate on serum indexes and immune response in patients with Parkinson's disease
by: Shi-Ping Sun, et al.
Published: (2016-11-01) -
Administration of troxerutin and cerebroprotein hydrolysate injection alleviates cerebral ischemia/reperfusion injury by down-regulating caspase molecules
by: Sui R, et al.
Published: (2019-08-01)